Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Hereditary Disease Foundation Raises $900,000 Toward Research Into Huntington's Disease and Other Brain Disorders At 50th Anniversary Gala

Hereditary Disease Foundation
Posted on: 09 Nov 17
Hereditary Disease Foundation Raises $900,000 Toward Research Into Huntington's Disease and Other Brain Disorders At 50th Anniversary Gala 2017 Leslie Gehry Brenner Prize for Innovation in Science Awarded to Professor Sarah Tabrizi of University College London Institute of Neurology Dr. Francis S. Collins, Director of the NIH, Is Keynote Speaker Milton Wexler Prize Awarded to Frank and Berta Gehry

PR Newswire

NEW YORK, Nov. 9, 2017

NEW YORK, Nov. 9, 2017 /PRNewswire/ -- The Hereditary Disease Foundation (HDF) held its 50th Anniversary Symposium and Gala at the Metropolitan Club in New York on November 6. Titled "A Celebration of 50 Years of Discovery," the evening included a scientific symposium and a dinner/awards ceremony. Dr. Sarah J. Tabrizi, co-founder and Director of the University College London (UCL) Huntington's Disease Centre at the UCL Institute of Neurology, received the 2017 Leslie Gehry Brenner Prize for Innovation in Science. Dr. Francis S. Collins, Director of the National Institutes of Health (NIH) was the keynote speaker. 

Dr. Nancy S. Wexler, President of the Hereditary Disease Foundation, said, "Dr. Tabrizi has channeled her passion for scientific research into discovering ways to prevent or reverse Huntington's disease." She and her superb global team are the principal investigators for the world's first gene silencing trial in Huntington's disease, begun in 2015 and sponsored by Ionis Pharmaceuticals.

Professor Tabrizi, said, "I am honored to receive this award and I am deeply grateful to the Hereditary Disease Foundation and to the Gehry family for their support of research that seeks to improve the lives of people with hereditary diseases such as Huntington's disease." 

Professor Tabrizi co-founded the UCL Huntington's Disease Centre in 2016 with Professor Gillian Bates, who won the Leslie Gehry Brenner Prize in 2012 for developing the first mouse model of Huntington's disease.

The Gehry prize was established by Frank and Berta Gehry to honor the memory of his daughter Leslie. The generous prize, bestowed annually, carries an award of $100,000 to support a scientist who exemplifies qualities of inventiveness and imagination in science. 

The Milton Wexler Prize was awarded to Berta Gehry and Frank O. Gehry, founding Trustees of the Hereditary Disease Foundation, for their tremendous contribution to the Foundation over the decades. 

The Hereditary Disease Foundation
The Hereditary Disease Foundation facilitates collaborative and innovative scientific research to further the understanding of Huntington's disease, a genetic disorder that strikes in early- to mid-adulthood, destroying brain cells, and bringing on severe and progressive declines in personality, cognitive ability, and mobility. As a disease caused by a mistake on a single gene, Huntington's disease is an ideal model for other brain disorders. Research organized by the Foundation led to the discovery of the genetic marker for Huntington's disease in 1983. The Foundation organized and funded a decade-long international collaboration of over 100 scientists who discovered the gene that causes Huntington's in 1993. This work played an important role in the development of the Human Genome Project. For information visit http://www.hdfoundation.org

View original content with multimedia:http://www.prnewswire.com/news-releases/hereditary-disease-foundation-raises-900000-toward-research-into-huntingtons-disease-and-other-brain-disorders-at-50th-anniversary-gala-300552654.html

SOURCE Hereditary Disease Foundation

PR Newswire
www.prnewswire.com

Last updated on: 09/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.